Indogulf Cropsciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
IGCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indogulf Cropsciences Limited submitted its audited financial results for FY25, which is also its first results filing after listing on NSE and BSE on July 3, 2025 following a recent IPO. The company operates in a single segment, agro-chemicals (technical and formulation). The auditor (Devesh Parekh & Co.) issued an unmodified opinion on both standalone and consolidated results, and the CFO separately declared the same. For the quarter ended March 31, 2025, standalone revenue from operations was about Rs 1,229 million, down from Rs 1,388 million in the same quarter last year. Exceptional items of Rs 13.49 million (gain on sale of fixed assets) were reported in FY25, compared to a Rs 36.65 million loss in FY24. Cash flow statements and balance sheets for both standalone and consolidated positions were also disclosed.
A clean, unmodified audit opinion is reassuring for a newly listed company, but the Q4 revenue decline and the relatively small scale of operations may draw investor attention. The exceptional item swing (from loss to gain) helps prop up reported profit, so underlying core earnings should be watched.